These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
172 related articles for article (PubMed ID: 28871238)
1. Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education. Saposnik G; Maurino J; Sempere AP; Terzaghi MA; Ruff CC; Mamdani M; Tobler PN; Montalban X Front Neurol; 2017; 8():430. PubMed ID: 28871238 [TBL] [Abstract][Full Text] [Related]
2. Effect of an Educational Intervention on Therapeutic Inertia in Neurologists With Expertise in Multiple Sclerosis: A Randomized Clinical Trial. Saposnik G; Grueschow M; Oh J; Terzaghi MA; Kostyrko P; Vaidyanathan S; Nisenbaum R; Ruff CC; Tobler PN JAMA Netw Open; 2020 Dec; 3(12):e2022227. PubMed ID: 33326024 [TBL] [Abstract][Full Text] [Related]
3. Traffic Lights Intervention Reduces Therapeutic Inertia: A Randomized Controlled Trial in Multiple Sclerosis Care. Saposnik G; Mamdani M; Montalban X; Terzaghi M; Silva B; Saladino ML; Tobler PN; Caceres F MDM Policy Pract; 2019; 4(1):2381468319855642. PubMed ID: 31259250 [No Abstract] [Full Text] [Related]
4. Therapeutic Inertia in Multiple Sclerosis Care: A Study of Canadian Neurologists. Saposnik G; Montalban X; Selchen D; Terzaghi MA; Bakdache F; Montoya A; Fruns M; Caceres F; Oh J Front Neurol; 2018; 9():781. PubMed ID: 30319523 [No Abstract] [Full Text] [Related]
5. Usability of an Educational Intervention to Overcome Therapeutic Inertia in Multiple Sclerosis Care. Saposnik G; Tobler PN; Caceres F; Terzaghi MA; Ruff C; Maurino J; Fruns Quintana M; Oh J; Montalban X; Mamdani M Front Neurol; 2018; 9():522. PubMed ID: 30042720 [No Abstract] [Full Text] [Related]
7. Comparison of Physician Therapeutic Inertia for Management of Patients With Multiple Sclerosis in Canada, Argentina, Chile, and Spain. Almusalam N; Oh J; Terzaghi M; Maurino J; Bakdache F; Montoya A; Caceres F; Saposnik G JAMA Netw Open; 2019 Jul; 2(7):e197093. PubMed ID: 31314113 [TBL] [Abstract][Full Text] [Related]
8. The Role of Prescribing Generic (Non-proprietary) Drugs in the Prevalence of Therapeutic Inertia in Multiple Sclerosis Care. Saposnik G; Mamdani M; Terzaghi M; Saladino ML; Silva B; Tobler PN; Caceres F Front Neurol; 2018; 9():835. PubMed ID: 30369904 [No Abstract] [Full Text] [Related]
9. Decision-making in Multiple Sclerosis: The Role of Aversion to Ambiguity for Therapeutic Inertia among Neurologists (DIScUTIR MS). Saposnik G; Sempere AP; Prefasi D; Selchen D; Ruff CC; Maurino J; Tobler PN Front Neurol; 2017; 8():65. PubMed ID: 28298899 [TBL] [Abstract][Full Text] [Related]
10. Factors associated with therapeutic inertia among pharmacists caring for people with multiple sclerosis. Terzaghi MA; Ruiz C; Martínez-López I; Pérez-Encinas M; Bakdache F; Maurino J; Saposnik G Mult Scler Relat Disord; 2020 Apr; 39():101887. PubMed ID: 31846865 [TBL] [Abstract][Full Text] [Related]
11. Effect of desire for pregnancy on decisions to escalate treatment in multiple sclerosis care: Differences between MS specialists and non-MS specialists. Saposnik G; Andhavarapu S; Fernández Ó; Kim HJ; Wiendl H; Foss M; Zuo F; Havrdová EK; Celius EG; Caceres F; Magyari M; Bermel R; Costa A; Terzaghi M; Kalincik T; Popescu V; Amato MP; Montalban X; Oh J Mult Scler Relat Disord; 2022 Jan; 57():103389. PubMed ID: 35158479 [TBL] [Abstract][Full Text] [Related]
12. Behavioral aspects of nurse practitioners associated with optimal multiple sclerosis care in Spain. Saposnik G; Del Río B; Bueno-Gil G; Sempere ÁP; Lendínez-Mesa A; Rodríguez-Antigüedad A; Terzaghi M; Medrano N; Maurino J PLoS One; 2021; 16(12):e0261050. PubMed ID: 34879095 [TBL] [Abstract][Full Text] [Related]
13. A multi-site, randomized controlled trial of MS INFoRm, a fatigue self-management website for persons with multiple sclerosis: rationale and study protocol. Finlayson M; Akbar N; Turpin K; Smyth P BMC Neurol; 2019 Jun; 19(1):142. PubMed ID: 31238966 [TBL] [Abstract][Full Text] [Related]
14. Nurse-led immunotreatment DEcision Coaching In people with Multiple Sclerosis (DECIMS) - Feasibility testing, pilot randomised controlled trial and mixed methods process evaluation. Rahn AC; Köpke S; Backhus I; Kasper J; Anger K; Untiedt B; Alegiani A; Kleiter I; Mühlhauser I; Heesen C Int J Nurs Stud; 2018 Feb; 78():26-36. PubMed ID: 28982479 [TBL] [Abstract][Full Text] [Related]